|
A digital imaging analysis (DIA) platform for identifying tertiary lymphoid structures (TLS) in lung adenocarcinoma (LUAD). |
|
|
|
Patents, Royalties, Other Intellectual Property - BostonGene (Inst) |
|
|
|
Patents, Royalties, Other Intellectual Property - BostonGene (Inst) |
|
|
|
Patents, Royalties, Other Intellectual Property - BostonGene (Inst) |
|
|
|
Patents, Royalties, Other Intellectual Property - BostonGene (Inst) |
|
|
|
|
|
|
|
|
|
Stock and Other Ownership Interests - BostonGene |
|
|
|
|
|
|
Stock and Other Ownership Interests - BostonGene (Inst) |
Patents, Royalties, Other Intellectual Property - BostonGene (Inst) |
|
|
|
|
|
|
Stock and Other Ownership Interests - BostonGene |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - Aptinyx; Moderna Therapeutics |
|
|
|
|
Stock and Other Ownership Interests - BostonGene |
|
Patents, Royalties, Other Intellectual Property - BostonGene |
|
|
|
Stock and Other Ownership Interests - BostonGene |
|
|
No Relationships to Disclose |